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SUMMARY
The macroautophagy machinery has been impli-
cated inMHC class II restricted antigen presentation.
Here, we report that this machinery assists in the
internalization of MHC class I molecules. In the
absence of the autophagy factors Atg5 and Atg7,
MHC class I surface levels are elevated due to
decreased endocytosis and degradation. Internaliza-
tion ofMHCclass Imolecules occurs less efficiently if
AAK1 cannot be recruited via Atg8/LC3B. In the
absence of Atg-dependent MHC class I internaliza-
tion, dendritic cells stimulate CD8+ T cell responses
more efficiently in vitro and in vivo. During viral infec-
tions, lack of Atg5 results in enhanced influenza-
and LCMV-specific CD8+ T cell responses in vivo.
Elevated influenza-specific CD8+ T cell responses
are associated with better immune control of this
infection. Thus, the macroautophagy machinery
orchestrates T cell immunity by supporting MHC
class II but compromises MHC class I restricted
antigen presentation.
INTRODUCTION
Macroautophagy is a major bulk degradative pathway in the cell,
acting in parallel to the proteasome to degrade intracellular pro-
teins and cell organelles (Mizushima et al., 2011). More than 30
autophagy related gene (atg) products form a double-membrane
vesicle that engulfs cytoplasmic constituents bound to Atg8, an
autophagy-related ubiquitin-like molecule that gets coupled to
autophagosomal membranes. Yeast Atg8 has at least seven or-
thologs in higher eukaryotic cells, namely LC3A-C, GABARAP,
and GABARAPL1-3. Initially thought to be a non-selective intra-
cellular pathway of bulk degradation, there is now growing evi-
dence that defines autophagy as a fine-tuned process with
high cargo selectivity. Indeed, autophagy receptors, such as
p62/sequestosome 1, optineurin, NBR-1, and NDP52, bind to
substrates and recruit them to autophagosomal membranes,
through binding of their LC3-interacting regions (LIRs) to Atg8
(Stolz et al., 2014). Autophagy substrates may comprise ubiqui-
tinated proteins, N-terminally arginylated proteins, proteins with
exposed glycosylation, and even organelles (Cha-Molstad et al.,
2015; Randow and M€unz, 2012). Macroautophagy is constitu-
tively active in leukocytes and can mediate both adaptive and
innate immune responses. During the innate immune response,
various Toll- and NOD-like receptors (TLRs and NLRs) can
enhance macroautophagy (Cooney et al., 2010; Delgado et al.,
2009). The pathway also directly degrades intracellular patho-
gens, and some bacteria and viruses have evolved to develop
strategies to escape autophagic degradation (Choi et al., 2013).
During the adaptive immune response, macroautophagy in
antigen-presenting cells has been shown to directly control
CD4+ T cell responses, by regulating the delivery of both endog-
enous proteins and exogenous phagocytosed antigens to major
histocompatibility complex (MHC) class II loading compartments
(Lee et al., 2010; Schmid andM€unz, 2007). Endogenous self-pro-
tein processing via macroautophagy contributes to both positive
and negative CD4+ T cell selection via presentation on MHC
class II molecules in the thymus (Aichinger et al., 2013; Nedjic
et al., 2008). This involves canonical macroautophagy and can
be increased by selective targeting to autophagosomes via anti-
gen fusion to LC3B. In contrast, exogenous antigen processing
for MHC class II presentation seems to utilize the macroautoph-
agymachinery via LC3-associated phagocytosis (LAP) (Ma et al.,
2012; Romao et al., 2013). In this pathway, LC3B is coupled to
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the cytosolic side of phagosomal membranes around cargo that
has stimulated the recruitment of NADPH oxidase (NOX2) to the
phagosomal membrane (Martinez et al., 2015; Romao et al.,
2013). Reactive oxygen species production by NOX2 is required
for LC3B recruitment to phagosomes, which, depending on
the cell type, seems to accelerate or attenuate fusion with
lysosomes. In the case of attenuation of lysosome fusion, MHC
class II presentation of the endocytosed antigens seems to be
prolonged (Romao et al., 2013).
Compared to antigen processing for MHC class II presenta-
tion, little is known about the mechanisms by which the macro-
autophagy machinery influences MHC class I restricted antigen
presentation. Here, we report that antigen-presenting cells, like
dendritic cells (DCs), which lack the core macroautophagy ma-
chinery that mediates Atg8 lipidation, have elevated surface
MHC class I expression. This results from attenuated internaliza-
tion and degradation of MHC class I molecules, and it involves
the adaptor-associated kinase 1 (AAK1), which is recruited to
MHC class I molecules via (presumably membrane-coupled)
LC3B. MHC class I surface stabilization on DCs lacking Atg8 lip-
idation is associated with enhanced CD8+ T cell responses dur-
ing influenza A virus (IAV) and lymphocytic choriomeningitis virus
(LCMV) infection, resulting in improved immune control of IAV.
These findings establish a role for the macroautophagy machin-
ery in controllingMHCclass I expression and in shaping anti-viral
CD8+ T cell responses.
RESULTS
Increased MHC Class I Levels on Autophagy-Deficient
atg5/ or atg7/ DCs and Macrophages In Vitro and
In Vivo
In order to address whether MHC class I presentation could be
affected by macroautophagy deficiency, we investigated mice
in which atg5 or atg7 was conditionally deleted in DCs and
CD11c-positive macrophages by crossing CD11c-cre mice
with atg5- or atg7-floxed mice (atg5/ or atg7/ DC mice).
Atg5 is a key component of the Atg8 E3-like ligase Atg5-
Atg12-Atg16L1, required for autophagosome formation, and
atg7 encodes the E1-like enzyme for both Atg8 and Atg12 conju-
gation. We analyzed the surface levels of the MHC class I
molecules H2-Kb and H2-Db on atg5-deficient cells by flow cy-
tometry. We found that atg5/ DCs and alveolar macrophages
displayed higher MHC class I cell surface expression at steady
state than their atg5fl/fl littermates (Figures 1A and 1B), as well
as compared to wild-type and CD11c-cre transgenic C57BL/6
mice (Figures S1B and S1C). Indeed, both H2-Kb and H2-Db
molecules of splenic CD11c+ cells were expressed at signifi-
cantly higher surface levels in atg5/ DC mice (Figures 1A,
1B, and S1A). This elevated H2-Kb and H2-Db expression was
observed on both CD11b+ and CD8+ subsets of splenic DCs.
In addition, MHC class I expression on tissue-resident CD11c+
cells was also significantly higher in the absence of atg5. In the
lungs, for example, H2-Db expression on CD11c+ alveolar mac-
rophages and CD11b+ and CD103+ DCs was significantly higher
on atg5/ cells (Figures 1A and 1B). Moreover, atg5-deficient
bone-marrow-derived DCs (BM-DCs) displayed higher MHC
class I levels than their wild-type counterparts (Figure 1C). In
contrast, MHC class I surface expression was unchanged on B
and T cells (Figures 1D and S1D). These data were confirmed
in atg7/ DC mice. Although deletion efficiency seemed to be
lower, resulting in residual LC3B lipidation in CD11c+ cells of
these mice (data not shown), MHC class I levels were elevated
on Atg7-deficient macrophage and DC populations, but not B
or T cells (Figures 1E, S1E, and S1F). These findings suggest
that deficiency in the core machinery of macroautophagy, which
is required for Atg8 lipidation, increases MHC class I levels on
myeloid antigen-presenting cells.
In order to address the mechanisms that could lead to MHC
class I upregulation in the absence of macroautophagy, we
tested four hypotheses. First, we ruled out a difference in MHC
class I gene expression, by quantifying MHC class I transcript
levels in flow cytometrically sorted splenic atg5+/+ and atg5/
DCs (Figure 2A). No difference in MHC class I transcription
was also confirmed in the investigated lung and splenic DC
and macrophage subpopulations (Figure 2B). These data indi-
cate that the increased MHC class I surface expression of mac-
roautophagy-deficient DCs is not due to altered MHC class I
gene transcription. We therefore addressed as the second hy-
pothesis a difference in the availability of ubiquitinated sub-
strates for proteasomal degradation and MHC class I loading.
We could not detect any difference in the total amount of polyu-
biquitinated proteins in atg5/DCs compared to atg5+/+ DCs by
western blot quantification (data not shown). As the third hypoth-
esis, a faster assembly or transport to the cell surface of new
MHC class I-peptide complexes was assessed in atg5/ DCs.
This could result from different mechanisms, as follows: a
compensatory proteasomal ligand generation, an increased pro-
teasomal activity in the absence of autophagic degradation of
this multi-catalytic protease, or an enhanced vesicular transport
to the cell surface (Dengjel et al., 2012; Marshall et al., 2015). We
did not see any difference in the rate of de novo expression of
MHC class I molecules on the cell surface as assessed after
acid stripping, which denatures surface MHC class I molecules,
followed bymeasuring the kinetics ofMHC class I recovery at the
cell surface (Figures 2C and 2D). These results taken together
suggest that the higher surface expression of MHC class I
molecules on atg5/ DCs is not related to enhanced gene tran-
scription, increased availability of antigenic peptides, or elevated
synthesis or trafficking of de novo formed MHC class I-peptide
complexes.
Deficiency in the Macroautophagy Machinery
Compromises MHC Class I Internalization by DCs
The fourth hypothesis explored a potentially attenuated inter-
nalization of MHC class I molecules in the absence of the
macroautophagy core machinery. Indeed, we found that anti-
body-labeled MHC class I molecules were internalized at a
slower rate in atg5/ compared to atg5+/+ DCs (Figures 3A
and S1G), increasing the difference in surface-labeled H2-Db
and H2-Kb molecules between Atg-deficient and sufficient DCs
over time (Figures 3B and S1H). Therefore, we concluded that
a reduced internalization rate is responsible for higher surface
expression of MHC class I molecules in atg5/ DCs and
increased stability of MHC class I complexes on the cell surface.
In good agreement with these findings, the total amount of MHC
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class I molecules was nearly 2-fold higher in extracts of atg5/
splenic DCs than in the respective atg5+/+ controls as deter-
mined by immunoblot quantification (Figures 3C and 3D),
suggesting enhanced degradation of MHC class I molecules af-
ter internalization in the presence of the macroautophagy core
machinery. In order to determine if this loss of internalization in
the absence of Atg5 also affected other surface receptors, we
tested the expression of CD29, CD44, transferrin receptor
(TfR), the co-stimulatory molecules CD80 and CD86, and MHC
class II. Only CD80 seemed to be regulated in a similar fashion
as MHC class I, as it showed a tendency toward stabilization
on the cell surface of some atg5/ DC populations (mainly
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Figure 1. Elevated MHC Class I Expression
on atg5- or atg7-Deficient DCs and Macro-
phages
(A) Expression of H2-Db on atg5+/+ and atg5/
DCs and macrophages. Splenic DCs were gated
as live CD11c+ MHC class IIhigh cells, excluding
inflammatory DCs and macrophages by using
both Ly6C and F4/80 staining. Among these
splenic DCs, H2-Db expression on CD11b+ and
CD8+ DCs was analyzed. Lung DCs were gated as
live CD11c+ MHC class IIhigh cells. DC subsets
were further subdivided on the basis of CD11b and
CD103 expression, and alveolar macrophages as
double negative CD11bCD103 cells. Inflam-
matory DCs and monocytes were gated out using
Ly6C staining. H2-Db expression on alveolar
macrophages, lung CD11b+, and CD103+ DCs
was analyzed.
(B) Graphs summarize mean fluorescence in-
tensity (MFI) values and SEM of H2-Db from three
independent experiments, each with three mice
per group.
(C) Expression of H2-Db on atg5+/+ and atg5/
BM-DCs. Representative flow cytometric staining
(above) and all results (below) are from five inde-
pendent experiments and are summarized as fold
increase compared to atg5+/+ DCs.
(D) MHC class I surface expression on B and
T cells for the experiments of (A). Mean and SEM
were plotted.
(E) Expression of MHC class I on atg7+/+ and
atg7/ alveolarmacrophages.Results are fromsix
independent experiments and are summarized as
fold increase compared to atg7+/+ macrophages.
Unpaired non-parametric two-tailed t tests were
performed to obtain the indicated p values.
CD8+ splenic DCs), while the surface
expression of the other investigated re-
ceptors was unchanged during steady
state as well as infection (Figures S2A–
S2F). Furthermore, we also observed
that vesicular MHC class I pools could
not be formed in alveolar macrophages
and DCs of atg5/ and atg7/ DC
mice (Figures 3E, 3F, S2G, and S2H).
Finally, lysosomal degradation of MHC
class I was also attenuated in Atg5-defi-
cient BM-DCs (Figures 3G and 3H). Treat-
ment with the lysomotrophic agent chloroquine (CQ), elevating
lysosomal pH and thereby inhibiting lysosomal hydrolases,
accumulated MHC class I molecules in wild-type, but not in
Atg5-deficient cells. In parallel LC3B-II also accumulated only
in Atg5-positive DCs. Thus, the macroautophagy machinery as-
sists in internalization and degradation of a subset of surface re-
ceptors, including MHC class I molecules, in DCs.
Atg Deficiency Compromises MHC Class I Association
with AAK1, which Regulates MHC Class I Internalization
In order to analyze the molecular mechanism by which the
macroautophagy machinery assists MHC I internalization and
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degradation, we immunoprecipitated MHC class I molecules
from atg5+/+ murine embryonic fibroblasts (MEFs) and
analyzed the results by mass spectrometry. We found the
following two molecules that were previously reported to
be involved in receptor-mediated endocytosis and degra-
dation (data not shown): the AAK1 (Conner and Schmid, 2002)
and the Ral A binding protein 1 (RALBP1) (Nakashima et al.,
1999).
First, we confirmed the mass spectrometry results by immu-
noprecipitation and western blot analysis. We were able to
identify both AAK1 and RALBP1 in MHC class I immune precip-
itates of both atg5/ and atg5+/+ BM-DCs (Figures 4A and
S3A). However, only the association of AAK1 with MHC
class I was significantly reduced in atg5/ BM-DCs, compared
to their wild-type counterparts (Figure 4A). In good agreement,
AAK1 association with MHC class I molecules was also
reduced in Atg7-deficient BM-DCs (Figure 4B). RNA silencing
of AAK1 stabilized MHC class I levels on both MEFs and
BM-DCs (Figures 4C, 4D, S3B, and S3C), confirming its previ-
ously published role during receptor internalization. Addition-
ally, using the iLIR platform (Kalvari I et al., 2014; http://
repeat.biol.ucy.ac.cy/iLIR/), we predicted two and one LIR
motifs in the murine AAK1 and RALBP1 proteins, respectively
(AAK1118–123: DVWEVL [score 18], AAK1914–919: DEFDPI [score
15], RALBP1318–323: LSWLIV [score 16]). Interestingly, the LIR
sequences are conserved in the human AAK1 protein, but not
in human RALBP1. We validated the interactions of LC3 with
AAK1 and RALBP1 by co-immunoprecipitations. Indeed, we
found that both AAK1 (Figure 4E) and RALBP1 (Figure S3D)
could be co-immunoprecipiated with LC3B, but this association
did not seem to be influenced by the macroautophagy core ma-
chinery. These data suggest that LC3 lipidation via the macro-
autophagy core machinery is required to efficiently localize
AAK1 to MHC class I molecules for optimal internalization and
degradation.
Enhanced Antigen Presentation on Stabilized MHC
Class I Molecules by Macroautophagy-Deficient DCs
In Vitro
In order to correlate the enhanced MHC class I expression on
atg5/DCs with better antigen presentation, we tested the abil-
ity of DCs deficient in the macroautophagy machinery to restim-
ulate anti-viral CD8+ T cell responses in vitro. We co-cultured
IAV-infected atg5+/+ or atg5/ DCs with virus-specific poly-
clonal memory T cells isolated from IAV-infected wild-type ani-
mals. We found that infected atg5/ DCs were able to expand
IAV-specific memory CD8+ T cells more efficiently than atg5+/+
DCs (Figures 5A and 5B). This applied to both influenza nucleo-
protein (NP)-specific and overall CD8+ T cell populations. In
contrast, IAV CD4+ T cell expansion was not significantly
different when stimulating with atg5/ or atg5+/+ influenza-
infected DCs (Figure S4A). Moreover, NP1366–374 peptide
epitope pulsed atg5/ DCs also expanded polyclonal IAV-
specific memory T cells more efficiently than atg5+/+ DCs (Fig-
ures 5C and 5D). Blocking CD80 during this in vitro restimulation
did not significantly affect T cell proliferation. Therefore, we
concluded that macroautophagy deficiency causes enhanced
antigen presentation of MHC class I restricted IAV-derived epi-
topes by DCs.
Elevated CD8+ T Cell Responses to Multiple IAV
Antigens during Infection of Mice with DCs that Lack
LC3 Lipidation
In order to validate our results in vivo, we infected atg5/ DC
mice and their wild-type littermates (atg5+/+ DC mice) with
a high dose (10 HAU) of IAV. The resulting CD8+ T cell re-
sponses specific for influenza antigens (NP1, NP2, and hemag-
glutinin [HA]) were markedly enhanced in mice lacking the
macroautophagy machinery in DCs. Indeed, the magnitude of
the specific CD8+ T cell response at day 11 post infection
was two to four times greater in atg5/ DC than in atg5+/+
atg5+/+ DC
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Figure 2. Similar MHC Class I Transcription
and Transport to the Cell Surface in atg5/-
Deficient DCs
(A) Quantification of MHC class I transcript level in
splenic atg5+/+ and atg5/ DCs. H2-Kb mRNA
levels were determined by qRT-PCR in FACS
sorted splenic DCs. Fold change in H2-Kb mRNA
of atg5/ cells compared to atg5+/+ cells is rep-
resented (values are calculated using the 2exp-
DDct formula). Data combine three independent
experiments.
(B) H2-Kb transcript levels in the indicated lung and
splenic DC and macrophage (AM) populations.
Data are from three mice per indicated experi-
mental group.
(C and D) Restoration of H2-Kb (C) and H2-Db (D)
surface expression over time, in atg5/ and
atg5+/+ DCs after acid stripping of surface mole-
cules. Graphs represent the mean of three inde-
pendent experiments.
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DC mice (Figures 6A and 6B). In parallel, the specificity of the
anti-viral CD8+ T cell responses was broader in atg5/ DC
animals since at least two additional subdominant CD8+
T cell epitopes (HA211–225 and NP2311–325) were recognized at
frequencies reaching 10% of CD8+ T cells apart from the domi-
nant NP1366–374 epitope in the C57BL/6 mouse background.
Accordingly, recognition of subdominant IAV epitopes reached
levels of wild-type dominant epitope recognition in atg5/ DC
mice.
Furthermore, we found that elevated CD8+ T cell responses
correlated with protection from IAV-induced disease. The infec-
tious lung viral titers at day 8 were significantly reduced in
atg5/ DC mice (Figure 6C). Additionally, a significant correla-
tion between themagnitude of the anti-viral CD8+ T cell response
and weight loss was observed (Figure 6D), indicating that the
increased CD8+ T cell responses in the absence of the macroau-
tophagy core machinery protected from morbidity during IAV
infection. The specific anti-viral CD4+ T cell responses and the
influenza-specific antibody titers were not significantly different
in atg5/ DC animals compared to their wild-type littermates
(atg5+/+ DC) (Figures S4B and S4C). In good agreement, MHC
class I surface expression remained elevated on Atg 5-deficient
DCs and macrophages during IAV infection (Figure S2E), while
with the exception of CD80 co-stimulatory molecules were
unchanged (Figure S2F). Thus, while the protective CD8+
T cell response is selectively enhanced in infected mice with
Atg5-deficient DCs, CD4+ T cell and antibody responses are
unaffected.
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G H
Figure 3. Atg Deficiency Compromises
MHC Class I Internalization
(A) Internalization of MHC class I molecules over
time in atg5/ and atg5+/+ DCs. Cells were
labeled with anti-H2-Kb-specific antibodies and
incubated at 37C for the indicated times. The rate
of internalization at 37C of H2-Kb molecules was
evaluated by the decrease of MFI intensity
compared to the MFI of control DCs incubated at
4C and set as a reference to 100%. p values are
from paired non-parametric two-tailed t tests.
(B) The MFI ratio of H2-Kb surface staining on
atg5/ compared to atg5+/+ DCs increases over
time during incubation at 37C. Statistics were
performed using paired non-parametric two-tailed
t tests to compare the MFI ratio (log values) of time
0 to 30 min (p = 0.015), to 60 min (p = 0.01), and to
90 min (ns, not significant). Graphs (A and B) are
the summary of three independent experiments.
(C) Immunoblot analysis of MHC class I protein
content in atg5/ and atg5+/+ splenic DCs. One
representative immunoblot out of five is shown.
Numbers below bands represent the ratio of
normalized intensity of the MHC class I band
compared to actin.
(D) Summary of the MHC class I quantification,
normalized to actin, for all five immunoblots as
described in (C).
(E) Immune fluorescence staining for H2-Kb on
atg5+/+ and atg5/ lung CD11c+ cells. Nuclear
DNA was counterstained with DAPI. Scale bar in-
dicates 10 mm.
(F) Quantification of vesicular (intracellular) MHC
class I staining in lungCD11c+ cells. Left: summary
of atg5+/+ and atg5/ and atg7+/+ and atg7/
lung CD11c+ cells. Right: quantification of atg5+/+
and atg5/ lung CD11c+ cells. The presented
data summarize three independent experiments.
(G) Immunoblot analysis of MHC class I protein
content in atg5/ and atg5+/+ BM-DCs with and
without chloroquine (CQ) treatment for 20 hr at
concentrations of 25 and 50 mM. One represen-
tative immunoblot out of three is shown.
(H) Summary of the MHC class I quantification,
normalized to actin, for all three immunoblots as
described in (G). p values were determined by
unpaired non-parametric two-tailed t tests.
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Figure 4. AAK1 Does Not Efficiently Associate with MHC Class I in the Absence of LC3B Lipidation
(A) AAK1 co-immunoprecipitation with MHC class I. Lysates of atg5/ and atg5+/+ BM-DCs were used to immunoprecipitate MHC class I. Left: representative
western blot analysis showing the co-immunopreciptation of AAK1 with MHC class I. Right: quantification of five independent experiments. Co-immunopre-
cipitation intensity of AAK1 was normalized to MHC class I intensity. The AAK1 amount co-immunoprecipitated from the atg5/ samples (n = 5, mean = 76.8%,
SEM is 5.9) and the atg5+/+ samples (set to 100% as a reference) were compared. p value shown is from an unpaired non-parametric two-tailed t test.
(B) Lysates of atg7/ and atg7+/+ BM-DCs were used to immunoprecipitate MHC class I. Left: representative western blot analysis showing the co-im-
munopreciptation of AAK1 with MHC class I. Right: quantification of three independent experiments. Co-immunoprecipitation intensity of AAK1 was normalized
to MHC class I intensity. The AAK1 amount co-immunoprecipitated from the atg7/ samples and the atg7+/+ samples (set to 100% as a reference) were
compared. p value shown is from an unpaired non-parametric two-tailed t test of the non-normalized values.
(legend continued on next page)
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Cytokine Production and Early Viral Titers in
IAV-Infected Mice with DCs that Lack Components of
the Macroautophagy Machinery
In order to exclude that changes in early innate immune control
and cytokines would allow IAV to replicate to higher viral titers re-
sulting in elevated IAV-specific CD8+ T cell responses in atg5/
DCmice,weanalyzedcytokine production and IAV titers onday3
after infection. Cytokine secretion in response to infection was
similar for interleukin-6 (IL-6) and interferon-g (IFN-g) in atg5/
DC mice (Figures S5A and S5B). IL-1b, however, was increased
(Figure S5C), but these elevated IL-1b levels were not able to
control IAV infection early on, as demonstrated by similar viral
titers between wild-type and knockout mice on day 3 after infec-
tion (Figure S5D). Therefore, changes in innate immune control
are unlikely to account for the elevated CD8+ T cell responses
and improved immune control in atg5/ DC mice.
(C) Immunoblot for AAK1 on lysates from MEFs with (AAK1 small interfering RNA [siRNA] D02) and without (control siRNA) RNA silencing of AAK1. One
representative of three experiments is shown.
(D) H2-Db surface expression levels onMEFs after AAK1 silencing with AAK1-specific siRNA aswell as control siRNA. Four experiments are summarized. p values
were obtained from unpaired non-parametric two-tailed t tests.
(E) AAK1 co-immunoprecipitate with LC3. Lysates from atg5/ and atg5+/+ BM-DCs were used to immune precipitate LC3. Left: representative western blot
analysis showing the co-immunoprecipitation of AAK1 with LC3. Right: quantification of three independent experiments. The co-immunoprecipitation intensity of
AAK1 was normalized to the total LC3 (I and II). The amount of AAK1 co-immunoprecipitated from the atg5/ samples (n = 3) and the atg5+/+ samples (set to
100% as a reference) were compared. Statistical analysis was performed with an unpaired non-parametric two-tailed t test (ns, not significant).
A B
C D
Figure 5. DCs Deficient in the Molecular Macroautophagy Machinery Have Greater Antigen Presentation Capacity to CD8+ T Cells In Vitro
(A) IAV-infected or control atg5/ and atg5+/+ splenic DCs were co-cultured with CFSE-labeled influenza-virus-specific polyclonal memory T cells isolated from
infected wild-type animals. T cell proliferation was determined after 3 days of co-culture by flow cytometry. Percent of CFSE low cells of influenza NP1366–374/
H2-Db tetramer-positive (TM-NP, upper row) or total IAV-specific CD8+ T cells (lower row) are indicated. One representative experiment out of three is shown.
(B) Graphical analysis of T cell proliferation from three independent experiments. p values were determined by unpaired non-parametric two-tailed t tests.
(C) NP1366–374 atg5
/ or atg5+/+ splenic DCs were co-cultured with CFSE-labeled influenza-virus-specific polyclonal memory T cells isolated from infected wild-
type animals. T cell proliferation was determined after 3 days of co-culture with CD80 blocking antibody (+aCD80) or isotype control (+isotype) by flow cytometry.
Percent of CFSE low cells of total CD8+ T cells are indicated. One representative experiment out of three is shown.
(D) Summary of CD8+ T cell proliferation assayswith 0.1 and 1 mMNP1366–374 peptide pulsed DCs as outlined in (C). p valueswere determined by paired two-tailed
t tests.
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Elevated CD8+ T Cell Responses to Two LCMV Epitopes
during Infection of Mice with DCs Deficient in the
Macroautophagy Machinery
In order to address the role of elevated MHC class I expression
on atg5/ DCs for better CD8+ T cell priming in a different infec-
tious model, we tested LCMV infection. atg5/ DC animals and
their wild-type littermates (atg5+/+ DC) were infected intrave-
nously (i.v.) with the wild-type LCMV Armstrong strain at a
dose of 104 PFU. The specific CD8+ T cell response to two viral
epitopes was monitored at day 6 and day 11 post infection. We
did not find a difference in the anti-viral CD8+ T cell response at
day 6 between the two groups (data not shown); however, at
day 11, the anti-viral CD8+ T cell response was significantly
elevated in atg5/ DC animals. The percentages of MHC
class I tetramer-positive cells that are specific to two viral
LCMV epitopes, the immunodominant H2-Db-NP396 and the
subdominant H2-Kb-GP34 epitope, were up to 2-fold higher in
atg5/ DC animals (Figures 7A and 7B). These data suggest
A B
C D
p=0.002
Figure 6. Broader Specificity and Enhanced Magnitude of Influenza-Specific CD8+ T Cell Responses in Mice Lacking atg5 in Their DCs
(A and B) Levels of influenza-virus-specific CD8+ T cells in the lungs of wild-type mice (atg5+/+ DC) and mice with atg5-deficient DCs (atg5/DC) were assessed
11 days after intranasal infection with 10 HA units of influenza virus strain A/PR8. Intracellular interferon-g (IFN-g) staining of CD8+ T cells after in vitro peptide
restimulation with three different viral epitopes (NP1366–374, NP2311–325, and HA211–225) was determined by flow cytometry. Background secretion was subtracted
for every peptide and was determined for every mouse by using an irrelevant peptide control (Ny-ESO-1157–170). (A) Representative FACS plots of PBS mock-
infected or influenza-infected mice. (B) Quantification of the specific anti-viral CD8+ T cell responses to the three different viral epitopes (NP1, HA, and NP2) or
their sum (S). Data are from three independent experiments, each with three to four mice per group. p values are from non-parametric unpaired two-tailed t tests.
(C) Influenza lung viral titers were determined at day 8 post influenza infection, from supernatants of total lung homogenates from atg5/ or atg5+/+ DC mice
infected with 10 HAU of influenza A/PR8. Unpaired non-parametric two-tailed t tests were used to obtain the indicated p values.
(D) The magnitude of the anti-viral CD8+ T cell response significantly inversely correlated with the weight loss at day 7 post influenza infection (p value is from
Spearman non-parametric test). Data were obtained from six independent experiments: three with 10 HAU and three with 0.1, 0.5, or 1 HAU.
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that stabilized MHC class I levels on macroautophagy-machin-
ery-deficient DCs contribute to elevated priming of anti-viral
CD8+ T cell responses in vivo.
DISCUSSION
Our studies describe a role for lipidated LC3B in recruiting the
internalization machinery to MHC class I molecules. In the
absenceof this recruitment,MHCclass I getsstabilizedon thesur-
face of myeloid antigen-presenting cells. This results in elevated
CD8+Tcell responsesduring IAVandLCMV infections. Therefore,
the macroautophagy machinery seems to attenuate MHC class I
restricted antigen presentation, while it was previously shown to
enhance MHC class II restricted antigen presentation.
MHC class I internalization seems to utilize at least two path-
ways. Recycling of MHC class I molecules has been shown to
follow an ADP-ribosylation factor 6 (ARF6)-dependent endocy-
tosis pathway (Naslavsky et al., 2004). This pathway is clathrin
and dynamin independent. In contrast, AAK1, whose recruitment
to MHC class I we found to be LC3B lipidation dependent, has
beenmainly implicated in clathrin- and dynamin-mediated endo-
cytosis (Conner and Schmid, 2002; Henderson and Conner,
2007). The latter pathway seems to lead to lysosomal degrada-
tion of MHC class I and is also targeted by the K3 and K5 ubiq-
uitin E3 ligases of the Kaposi sarcoma-associated herpesvirus
(KSHV) (Coscoy et al., 2001; Hewitt et al., 2002). Interestingly,
an ubiquitin mutant that affects this MHC class I internalization
for degradation by K3 also affects MHC class I surface stability
of cells that do not express these viral proteins (Duncan et al.,
2010), suggesting that possibly membrane-associated RING-
CH (MARCH) E3-ubiquitin ligases engage the same pathway.
Indeed, MARCH4 and MARCH9 overexpression has been
shown to stimulate MHC class I internalization for degradation
(Nathan and Lehner, 2009). Thus, AAK1 recruitment via LC3B
lipidation seems to assist MHC class I internalization for
degradation, possibly enhancing an ubiquitin, clathrin- and dy-
namin-dependent internalization pathway. Compromising this
internalization pathway seemed to also deplete the recently
described vesicular MHC class I pools (Nair-Gupta et al.,
2014), which were described to supply MHC class I molecules
for cross-presentation of TLR engaging antigens. Interestingly,
the macroautophagy machinery has been previously suggested
to support clathrin-dependent endocytosis. Components of the
AP2 complex, which is also directly phosphorylated by AAK1,
have been found to interact with lipidated LC3B for Alzheimer
precursor protein internalization and degradation (Tian et al.,
2013). However, we did not find AP2 components significantly
enriched in MHC class I immunoprecipitates (data not shown),
and AAK1 can also support AP2-independent, but clathrin-
dependent, endocytosis (Gupta-Rossi et al., 2011; Henderson
and Conner, 2007). Thus, LC3B lipidation seems to affect
different clathrin-dependent internalization and degradation
steps of surface receptors, including MHC class I endocytosis.
We found that Atg-dependent MHC class I stabilization is
associated with elevated CD8+ T cell stimulation in vitro and
in vivo. In addition, various contributions of the macroautophagy
machinery to antigen processing for MHC class I presentation
have been reported. While some studies found that Atg defi-
ciency in antigen-presenting cells did not affect exogenous anti-
gen cross-presentation to CD8+ T cells (Lee et al., 2010), others
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Figure 7. Enhanced LCMV-Specific CD8+ T Cell Responses in Mice Lacking the Macroautophagy Machinery in Their DCs
(A and B) atg5/ DC animals and their wild-type littermates (atg5+/+ DC) were infected intravenously (i.v.) with the wild-type LCMV Armstrong strain at a dose of
104 PFU. The specific CD8+ T cell response to two viral epitopes was monitored in the blood, at day 11 post infection, using specific MHC class I tetramers. Data
are from three independent experiments, each with three to four mice per group. (A) Percentage of MHC I tetramer-positive cells of CD8+ T cells specific for the
H2-Db restricted NP396–404 (D
b-NP396, upper row) or the H2-Kb restricted GP34–43 (K
b-GP34, lower row) epitope in the blood of atg5+/+ or atg5/ DC mice.
(B) Combined data as in (A) for all three experiments. Paired non-parametric two-tailed t tests were performed on themean values from each experiment to obtain
the indicated p values.
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have shown that the macroautophagy machinery enhances
(Fiegl et al., 2013; Mintern et al., 2015) or inhibits (Baghdadi
et al., 2013; Hubbard-Lucey et al., 2014) cross-presentation.
Moreover, it has been suggested that the macroautophagy ma-
chinery supports packaging of antigens in antigen donor cells for
efficient cross-presentation (Li et al., 2008; Uhl et al., 2009). With
respect to endogenous antigens, targeting of antigens to auto-
phagosomes via fusion constructs with LC3B did not signifi-
cantly enhance MHC class I presentation (Schmid et al., 2007),
andmacroautophagy seems to even restrict MHC class I antigen
presentation of defective ribosomal products (Wenger et al.,
2012). However, under conditions of inhibition of the classical
MHC class I antigen processing pathway late in herpesvirus in-
fections, it was reported that macroautophagy can deliver anti-
gens for MHC class I presentation (English et al., 2009; Tey
and Khanna, 2012). While most of these studies investigated
the loss of components in the macroautophagy machinery
in vitro, we and others have noted hyper-reactivity of CD8+
T cell responses in the absence of Atgs in antigen-presenting
cells (Hubbard-Lucey et al., 2014) and in colorectal tumor cells
(Le´vy et al., 2015), and we demonstrate in this study that MHC
class I stabilization on DCs is associated with elevated anti-viral
CD8+ T cell responses in vivo. Nevertheless, we cannot exclude
that in addition to MHC class I stabilization additional factors
contribute to the increased CD8+ T cell responses to viral infec-
tions in mice with Atg deficiency in DCs. Along these lines both
the elevated CD80 surface expression on at least some subsets
of DCs and the increased IL-1bproduction early during IAV infec-
tion could contribute.
Our study sheds light on the molecular mechanism of MHC
class I internalization and degradation, involving recruitment of
the internalization factor AAK1 via LC3B lipidation in this pro-
cess. Thus, Atgs seem to balance MHC class I and II antigen
presentation, being beneficial for CD4+ T cell stimulation and re-
stricting CD8+ T cell responses at the same time. A comprehen-
sive understanding of how the macroautophagy machinery
interferes with MHC restricted antigen presentation seems
required to predict the outcome of therapeutic interventions in
this pathway to boost adaptive immunity.
EXPERIMENTAL PROCEDURES
Animals
8- to 12-week-old C57BL/6 (Janvier), atg5flox/flox (Hara et al., 2006), atg7flox/flox
(Komatsu et al., 2005), and CD11c-Cre Tg (Jackson ImmunoResearch Labora-
tories) were bred in the UZH animal facility. All procedures used in the study
complied with Swiss federal law for animal experimental procedures. All ani-
mal protocols were approved by the cantonal veterinary offices of the cantons
of Z€urich or of Geneva, Switzerland (protocol No. 117/2008, 134/2011, Mede-
cine FRM 1005, and ZH210/2014).
Influenza Virus Infection In Vivo
Influenza A/PR8 virus (H1N1) viruswas used for all experiments and purchased
from Charles River. Mice were anesthetized and infected intra-nasally by the
application of 25 ml of virus suspension (doses of virus were chosen between
0.1 and 10 HA units depending on the experiment).
Influenza Virus Infection In Vitro
CD11c+ magnetic cell separation (MACS) sorted splenic DCs were infected at
a MOI of 200 for 45 min in RPMI without serum.
LCMV Infection In Vivo
Animals were infected intravenously with the wild-type LCMV Armstrong strain
at a dose of 104 PFU.
Mouse DCs
Splenic and lung CD11c+ cells were isolated by positive magnetic cell separa-
tion (Miltenyi Biotec) and cultured in R10 (RPMI 1640 supplemented with 10%
fetal calf serum [FCS]) and granulocyte-macrophage colony-stimulating factor
(GM-CSF). Where indicated, CD11c+ MHC class IIhigh cells were sorted on a
FACS Aria Cell Sorter II (BD Biosciences).
BM-DCs were expanded using 20 ng/ml GM-CSF supplemented media and
used at day 10. BM-DCpurity was checked by FACS analysis, and if necessary
(<80% CD11c+ MHC class IIhigh cells), cells were enriched by positive CD11c
selection.
Antibodies
Primary Antibodies for Flow Cytometry
The following mAbs were purchased from BD Biosciences or BioLegend
(unless otherwise stated), as conjugated to phycoerythrin (PE), PE-Cy7,
PerCP-Cy5.5, APC, APC-Cy7, Alexa Fluor 700, Pacific Blue, or biotin: anti-
CD4(GK1.5), -CD8 (53-6.7), -CD11c (N418), -CD11b (M1/70), -F4/80
(BM8), -Ly6C (HK1.4), -CD103 (2E7), -CD80 (16-10A1), -CD86 (GL-1), -H2-Kb
(AF6-88.5), -H2-Db (KH95), -H2 class I (M1/42), -CD71 (RI7217) -CD80(16-
10A1), -I-A/I-E (M5/114.15.2), and -IFN-g (XMG1.2). For staining with bio-
tinylated mAbs, samples were incubated with PE conjugated streptavidin.
Anti-mouse CD16/32 for Fc receptor blocking was purchased from BD
Biosciences. H2-Db/ASNENMETM-PE tetramers were obtained from Immu-
dex, and LCMV tetramers were purchased from TCmetrix. For detection of
influenza infected cells, mouse monoclonal anti-influenza M2-E10 antibody
was used (a gift from Dr. Tom Moran, New York, USA).
Primary Antibodies for Immunoblot Detection
The following primary antibodies were used: rabbit anti H2-Kb (Exon-8) (a gift
from Dr. Jack Bennink, Bethesda, MD), anti-actin-HRP (Sigma-Aldrich),
mouse anti-Atg5 (Nanotools), rabbit anti-LC3 (MBL International), mouse
anti-LC3 (clone 5F10-Nanotools), rabbit anti-AAK1 (Abcam), and rabbit anti-
RALBP1 (EMELCA).
Secondary Antibodies for Immunoblot Detection
The clean blot-HRP antibody (Life Technologies) and a goat-anti-mouse HRP
(Bio-Rad) were used.
Peptides, Chemicals, and Inhibitors
Peptides were synthesized by GL Biochem at a purity > 90%. Carboxyfluores-
cein succinimidyl ester (CFSE) was used at 0.5 mM and was from Molecular
Probes.
Flow Cytometry
Cells were acquired on a FACSFortessa flow cytometer using FACSDiva
Version 6.1.3 software (BD Biosciences) or a FACSCanto II (BD Biosciences),
and all flow cytometry analyses were performed with FlowJo Version 9.3.1
software (Treestar).
Influenza-Virus-Specific T Cell Proliferation
Influenza-specific polyclonal T cells were expanded from splenocytes of wild-
type mice at day 12/14 post influenza infection, as previously described
(Longhi et al., 2009), and cultured for 6/7 days in RPMI supplemented with
10% FCS and 40 units/ml of IL-2. For DC/T cell co-cultures, atg5+/+ and
atg5/ splenic DC were influenza infected in vitro at a MOI of 200 and seeded
overnight in R5 supplemented with GM-CSF or pulsed with 0.1 or 1 mM
NP1366–374 peptide for 1 hr. DCs were then co-cultured in 96 flat-bottom
plates, at a 1/1 ratio with CFSE-labeled IAV-specific T cells (obtained from
polyclonal T cell lines, or from lungs of wild-type infected animals). Co-culture
with non-infected DCs was used as a control. Where indicated, CD80-specific
blocking antibodies were added (10 mg/ml of clone 16-10A1) during the DC co-
culture with T cells.
Intracellular IFN-g Staining
Lung single-cell suspensions obtained after Percoll gradient centrifugation
were incubated in R10 at 37C for 5 hr in the presence of CD28- (2 mg/ml)
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and influenza-specific peptides (10 mg/ml). Brefeldin A (10 mg/ml) was added
after the first hour. Extracellular staining was performed (CD4, CD8, and live/
dead Aqua). Then cells were fixed and permeabilized using a BD Cytofix
Cytoperm Fixation/Permeabilization Kit and stained for IFN-g.
ELISA Assay
For detection of cytokines in the lungs, lungs were weighted and resuspended
in PBS (0.4 mg in 1.5 ml), then disrupted mechanically, using a Polytron.
Homogenates were then centrifuged at 13,000 RPM for 30 min, and superna-
tants were tested for cytokine detection. Mouse Il-6 and IFN-g ELISA kits were
purchased from BioLegend. The mouse IL-1b ELISA kit was purchased from
eBioscience or R&D.
MHC Class I Assays
Internalization assay was performed using anti-H2-Db and anti-H2-Kb bio-
tinylated antibodies. Briefly, CD11c MACS sorted DCs were stained in FACS
buffer (PBS supplemented with 2% FCS and 0.01% Na azide) for 30 min at
4C. Cells were washed two times in PBS, resuspended in R10, and kept at
4C or incubated at 37C for 30, 60, and 90min. After the incubation time, cells
were washed and surface staining was performed at 4C with PE coupled
streptavidin, anti-CD11c, anti-MHC class II, and Aqua.
Acid Stripping Assay
CD11cMACS sorted DCswere incubated for 2min with ice-cold acid stripping
buffer (131 mM sodium citrate, 66 mM sodium phosphate, and 1% BSA
[pH 3]), then washed two times in R10 and kept at 4C or incubated in R10
at 37C for the indicated time points. After the incubation time, cells were
washed and surface staining was performed at 4C with anti-H2-Db or anti-
H2-Kb, anti-CD11c, anti-MHC II, and Aqua.
Immunoprecipitation
Lysates from BM-DCs were used at day 10 post differentiation. Cells were
lysed in a 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-40 buffer supple-
mented with protease inhibitors (Roche). Equal protein amounts from atg5/
and atg5+/+ lysates were used after bicinchoninic acid assay quantification.
A minimum input of 1 mg was used per condition. Following a pre-clearing
step of 1 hr, lysates were immunoprecipitated overnight at 4C using either
anti-MHC class I (exon8) or anti-LC3 (MBL International) antibodies. In parallel
a rabbit control serumwas used as a negative control. The next day cell lysates
were further incubated with protein A beads (Pierce) for 2 hr. After five washes,
beads were denaturated in SDS page loading buffer and co-immunoprecipi-
tated proteins were analyzed by western blot. Immunoblot quantification
was done using the Image J software.
Immune Fluorescence Microscopy
CD11c-positive cells were cultured overnight at 37C in complete RPMI on
coverslips. The next day, cells were washed in PBS three times and incu-
bated with Fc blocker 2.4G2 Fcc III/II (BD Pharmingen) for 30 min at 4C, fol-
lowed by labeling for H2-Kb (antibody AF6-88.5) or H2 class I (antibody
M1/42) for 30 min at 4C. Next, they were incubated at 37C for 1 hr, washed
with PBS, and fixed in 4% paraformaldehyde 20 min at room temperature.
Cells were washed with PBS, permeabilized with 0.1% Triton X-100, and
saturated with 1% BSA for 1 hr. Binding of the primary antibody was de-
tected with Alexa Fluor 555 goat anti-rat IgG H&L, and cell nuclei were
stained with DAPI. Fluorescence was analyzed with a confocal laser scan-
ning microscope.
Statistical Analysis
Statistical significance was tested by Student’s t test with PRISM software
(Version 5; GraphPad software). p values of less than 0.05 were considered
statistically significant.
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